(678) 892-9230
Find Labs
Clinician-Led Care
Weight Loss · Hormones · Aesthetics
Telehealth Care Available
Book Consultation
Hormone Therapy · Education

What Is Progesterone and Why Do You Need It on HRT?

By Tactus Health Medical TeamMedically Reviewed by Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BCHormone Therapy6 min read

Progesterone is the second major female sex hormone, alongside estrogen, and it plays a role in hormone therapy that is frequently misunderstood by patients starting HRT. Many women are told they need progesterone “to protect the uterus” and nothing more. That framing is both incomplete and undersells the independent benefits progesterone contributes to the HRT protocol. Understanding what progesterone actually does explains why it matters beyond uterine protection and why the type of progesterone prescribed has real clinical consequences.

Key takeaway: Progesterone on HRT does more than protect the uterus. Micronized bioidentical progesterone (Prometrium) supports sleep, mood, and breast safety, and it has a meaningfully different clinical profile than synthetic progestins. The choice between bioidentical progesterone and synthetic progestin is one of the most important decisions in an HRT protocol.

Progesterone’s Role in the Body

Progesterone is produced primarily by the corpus luteum after ovulation in the second half of the menstrual cycle, and in large amounts by the placenta during pregnancy. It has receptors throughout the body, including the uterus, brain, breasts, bone, blood vessels, and gastrointestinal tract. Its effects extend well beyond reproduction:

  • Uterine protection. Estrogen stimulates the proliferation of the uterine lining (endometrium). Unopposed estrogen, meaning estrogen without progesterone in women who still have a uterus, significantly increases the risk of endometrial hyperplasia and endometrial cancer. Progesterone opposes this effect by causing the endometrium to differentiate and shed rather than continue proliferating. This is why women with an intact uterus require progesterone alongside estrogen.
  • Sleep. Progesterone metabolizes in the brain to a compound called allopregnanolone, which activates GABA-A receptors, the same receptors targeted by benzodiazepines and alcohol. This produces anxiolytic and sedative effects. Oral micronized progesterone taken at bedtime is one of the most effective sleep aids available for perimenopausal women, with a safety profile far superior to prescription sleep medications.
  • Mood. Progesterone’s GABA-activating metabolites reduce anxiety, lower stress reactivity, and stabilize mood. The premenstrual irritability and anxiety that many women experience reflects the rapid fall of progesterone in the late luteal phase. Restoring progesterone in perimenopause addresses one of the primary drivers of mood volatility.
  • Breast tissue. The type of progestogen matters significantly for breast tissue effects. Micronized bioidentical progesterone appears to have a neutral or protective effect on breast tissue compared to the proliferative effects seen with synthetic progestins like medroxyprogesterone acetate.

Bioidentical Progesterone HRT vs Synthetic Progestins: A Critical Difference

All progestogens are not the same. The terms progesterone and progestin are often used interchangeably but describe chemically distinct compounds with meaningfully different receptor profiles and clinical effects.

Micronized bioidentical progesterone (Prometrium, generic micronized progesterone) is molecularly identical to the progesterone the human body produces. It metabolizes to allopregnanolone, producing the sleep and mood benefits described above. Its breast safety profile is more favorable than synthetic progestins in multiple large observational studies, including the French E3N cohort study by Fournier and colleagues, which found differential breast cancer risk between bioidentical progesterone and synthetic progestins in over 80,000 women.

Synthetic progestins (medroxyprogesterone acetate, levonorgestrel, norethindrone, and others) are chemically distinct molecules that activate progesterone receptors but do not metabolize to allopregnanolone. They do not provide the sleep or mood benefits of bioidentical progesterone. The increased breast cancer risk associated with combined HRT in the WHI trial was specifically associated with medroxyprogesterone acetate combined with conjugated equine estrogen. The WHI studied oral conjugated equine estrogen plus medroxyprogesterone acetate, not the modern formulation of transdermal estradiol plus micronized progesterone used today, which is one reason the original WHI risk numbers do not translate cleanly to current bioidentical protocols.

At Tactus Health, our HRT program prescribes oral micronized progesterone (Prometrium) rather than synthetic progestins for all HRT patients who require a progestogen. The 2022 Menopause Society position statement on hormone therapy recognizes the favorable profile of micronized progesterone in observational data and supports its use as a preferred progestogen.

Current evidence supports initiating HRT within 10 years of the menopausal transition, or before age 60, for the most favorable benefit-to-risk profile. For a fuller comparison of the bioidentical and synthetic categories, see our guide on BHRT vs synthetic HRT.

Do Women Without a Uterus Need Progesterone?

Women who have had a hysterectomy do not require progesterone for uterine protection, since there is no endometrium to protect. Whether to include progesterone in the HRT protocol for hysterectomized women is a clinical decision based on the individual patient’s sleep quality, mood, anxiety, and personal preferences. Some hysterectomized women report significant benefit from oral micronized progesterone for sleep and mood independently of any uterine protection rationale. Others do well on estrogen alone. Our medical team discusses both options and the evidence at the initial consultation.

Clinical note on dosing and timing: Oral micronized progesterone (typically 100 to 200 mg) is taken at bedtime. This timing takes advantage of the sedative metabolite effect and separates progesterone from daytime activities where sedation would be unwanted. Morning progesterone dosing is less common and typically reserved for patients who experience next-day sedation at standard bedtime dosing. Vaginal micronized progesterone is another option in select cases.

Your HRT Protocol Should Use the Right Progesterone

At Tactus Health, our HRT program uses bioidentical micronized progesterone as standard, paired with transdermal estradiol when appropriate. Free consultation in Sugar Hill, GA or telehealth for Georgia patients.

Book Free Consultation
Terms defined in this post
Micronized bioidentical progesterone
Progesterone identical to what the ovaries produce, processed into small particles for oral absorption. Brand name Prometrium. Metabolizes to allopregnanolone in the brain, producing sleep and mood benefits in addition to uterine protection.
Synthetic progestin
A chemically distinct compound that activates progesterone receptors but is not molecularly identical to natural progesterone. Examples include medroxyprogesterone acetate, levonorgestrel, and norethindrone. Does not metabolize to allopregnanolone, so does not provide the sleep or mood benefits of bioidentical progesterone.
Allopregnanolone
A neurosteroid produced from the metabolism of progesterone in the brain. Activates GABA-A receptors and produces sedative and anti-anxiety effects, the same receptor system targeted by benzodiazepines and alcohol.
Endometrial hyperplasia
Excessive proliferation of the uterine lining, which can be a precursor to endometrial cancer. Caused by unopposed estrogen exposure in women with an intact uterus, which is why progesterone is required alongside estrogen in HRT.
Medroxyprogesterone acetate (MPA)
The synthetic progestin used in the WHI combined arm. Now considered responsible for most of the breast cancer signal seen in that trial. Chemically different from the progesterone the body produces.
TH
Written By
Tactus Health Medical Team

Clinical content researched and written by the Tactus Health team in Sugar Hill, GA. All hormone therapy articles are reviewed by Dr. Ashar before publication.

Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC reviewing progesterone HRT article at Tactus Health
Medically Reviewed By
Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC

Co-Founder & Medical Director at Tactus Health. Dual board-certified, with clinical focus on hormone therapy, medical weight loss, and aesthetics. Sugar Hill, GA and telehealth for Georgia patients.

Share this article
Email
See our articles more often in your Google results.
Medical Disclaimer: This article is for informational purposes only. Consult a qualified healthcare provider before starting or modifying any hormone therapy. Individual hormonal profiles and risk factors vary.